← All organizations

Edge Therapeutics Inc

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 1, 2016

Acquired by PDS Biotechnology Corp. on Mar 1, 2019

Timeline

2000s

Jun 1, 2009
Edge Therapeutics Inc— Founded

2010s

Mar 1, 2019
PDS Biotechnology Corp.— Acquired By

Drugs by trial phase (1 distinct, 3 trials)

Phase 3 (1 own, 0 via acquisition)

nimodipine

Indications

Studied for

Recent trials (5)

NCT02893826Study chairPhase 1Sep 1, 2016
NCT02893826Lead sponsorPhase 1Sep 1, 2016
NCT02790632Lead sponsorPhase 3Jul 1, 2016
NCT02790632Study chairPhase 3Jul 1, 2016
NCT01893190Lead sponsorPhase 1/Phase 2Sep 1, 2013

Details

Founded: Berkeley Heights, NJ, US Jun 1, 2009
Last known activity: Sep 1, 2016